Eto, Takashi
Karasuyama, Yuji
González, Verónica
Del Campo García, Ana http://orcid.org/0000-0003-2709-5583
Clinical trials referenced in this document:
Documents that mention this clinical trial
A randomized, single-dose, pharmacokinetic equivalence study comparing MB02 (proposed biosimilar) and reference bevacizumab in healthy Japanese male volunteers
https://doi.org/10.1007/s00280-021-04324-z
Funding for this research was provided by:
mAbxience Research SL
Article History
Received: 31 March 2021
Accepted: 6 July 2021
First Online: 16 July 2021
Declarations
:
: VG and ADCG are employees of mAbxience Research SL. The other authors declare that they have no conflict of interest.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Souseikai Hakata Clinic (Japan).
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.